NIH-funded research R21 grant

Investigating how a specific protein affects heart disease protection

Official title: Role of PKC Epsilon in Atheroprotection

Funded at Albany Medical College · NIH-11096137 · Data updated 2026-11-12

This study is looking at a protein called PKC Epsilon to see how it helps the body deal with heart disease by reducing inflammation and plaque buildup in arteries, which could lead to new ways to prevent heart problems, especially in older adults.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2027
Funding year2025
Award (this year)$238,620
NIH project number1R21AI185827-01A1
Project IDNIH-11096137 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults at risk for cardiovascular disease, especially those with high cholesterol levels.

Less likely to help

Patients who are not at risk for cardiovascular disease or who have other unrelated health conditions may not benefit from this research.

What this research studies

This research explores the role of a protein called PKC Epsilon in the body's response to heart disease, particularly focusing on how it influences inflammation and the resolution of that inflammation. By studying genetically modified mice, the researchers aim to understand how this protein can help reduce plaque buildup in arteries, which is a key factor in cardiovascular disease. The approach involves examining the signaling pathways that link the uptake of harmful substances to the body's ability to heal and resolve inflammation. This could lead to new insights into preventing heart disease in older adults.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better manage or prevent cardiovascular disease, particularly in older adults.

How similar studies have gone: Previous research has shown promising results in understanding the role of inflammation in cardiovascular disease, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Lennartz, Michelle R — Albany Medical College
  • Study coordinator: Lennartz, Michelle R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.